Cargando…

Prevalence of Transmitted Drug Resistance and Impact of Transmitted Resistance on Treatment Success in the German HIV-1 Seroconverter Cohort

BACKGROUND: The aim of this study is to analyse the prevalence of transmitted drug resistance, TDR, and the impact of TDR on treatment success in the German HIV-1 Seroconverter Cohort. METHODS: Genotypic resistance analysis was performed in treatment-naïve study patients whose sample was available 1...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bartmeyer, Barbara, Kuecherer, Claudia, Houareau, Claudia, Werning, Johanna, Keeren, Kathrin, Somogyi, Sybille, Kollan, Christian, Jessen, Heiko, Dupke, Stephan, Hamouda, Osamah
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2010
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2951346/ https://www.ncbi.nlm.nih.gov/pubmed/20949104 http://dx.doi.org/10.1371/journal.pone.0012718

Ejemplares similares

First Line Treatment Response in Patients with Transmitted HIV Drug Resistance and Well Defined Time Point of HIV Infection: Updated Results from the German HIV-1 Seroconverter Study
por: zu Knyphausen, Fabia, et al.
Publicado: (2014)

Prevalence and persistence of transmitted drug resistance mutations in the German HIV-1 Seroconverter Study Cohort
por: Machnowska, Patrycja, et al.
Publicado: (2019)

The risk of AIDS-defining events is decreasing over time in the German HIV-1 Seroconverter Cohort
por: Altmann, Mathias, et al.
Publicado: (2012)

Improved Testing of Recent HIV-1 Infections with the BioRad Avidity Assay Compared to the Limiting Antigen Avidity Assay and BED Capture Enzyme Immunoassay: Evaluation Using Reference Sample Panels from the German Seroconverter Cohort
por: Hauser, Andrea, et al.
Publicado: (2014)

CCR5Δ32 Genotypes in a German HIV-1 Seroconverter Cohort and Report of HIV-1 Infection in a CCR5Δ32 Homozygous Individual
por: Oh, Djin-Ye, et al.
Publicado: (2008)

Analysis of transmitted drug resistance and HIV-1 subtypes using dried serum spots of recently HIV-infected individuals in 2013 in Germany
por: Andrea, Hauser, et al.
Publicado: (2014)

Estimating Trends in the Proportion of Transmitted and Acquired HIV Drug Resistance in a Long Term Observational Cohort in Germany
por: Schmidt, Daniel, et al.
Publicado: (2014)

Tuberculosis among people living with HIV/AIDS in the German ClinSurv HIV Cohort: long-term incidence and risk factors
por: Karo, Basel, et al.
Publicado: (2014)

The denominator problem: Estimating MSM-specific incidence of sexually transmitted infections and prevalence of HIV using population sizes of MSM derived from Internet surveys
por: Marcus, Ulrich, et al.
Publicado: (2009)

Everything counts - a method to determine viral suppression among people living with HIV using longitudinal data for the HIV care continuum - results of two large, German, multi-center real-life cohort studies over 20 years (1999–2018)
por: Schmidt, Daniel, et al.
Publicado: (2021)

High Prevalence and High Incidence of Coinfection with Hepatitis B, Hepatitis C, and Syphilis and Low Rate of Effective Vaccination against Hepatitis B in HIV-Positive Men Who Have Sex with Men with Known Date of HIV Seroconversion in Germany
por: Jansen, Klaus, et al.
Publicado: (2015)

Prevalence of Transmitted Drug-Resistance Mutations and Polymorphisms in HIV-1 Reverse Transcriptase, Protease, and gp41 Sequences Among Recent Seroconverters in Southern Poland
por: Smoleń-Dzirba, Joanna, et al.
Publicado: (2017)

Patterns of Transmitted HIV Drug Resistance in Europe Vary by Risk Group
por: Frentz, Dineke, et al.
Publicado: (2014)

Molecular evolution of HIV-1 integrase during the 20 years prior to the first approval of integrase inhibitors
por: Meixenberger, Karolin, et al.
Publicado: (2017)

HIV-Prevalence in Tuberculosis Patients in Germany, 2002–2009: An Estimation Based on HIV and Tuberculosis Surveillance Data
por: Fiebig, Lena, et al.
Publicado: (2012)

Low incidence of HIV infection and decreasing incidence of sexually transmitted infections among PrEP users in 2020 in Germany
por: Schmidt, Daniel, et al.
Publicado: (2022)

Highly variable use of diagnostic methods for sexually transmitted infections-results of a nationwide survey, Germany 2005
por: Gilsdorf, Andreas, et al.
Publicado: (2010)

Transmitted drug resistance and subtype patterns of viruses from reported new HIV diagnoses in Germany, 2017–2020
por: Fiebig, Uwe, et al.
Publicado: (2023)

CD4-cell counts and presence of AIDS in HIV-positive patients entering specialized care—a comparison of migrant groups in the German ClinSurv HIV Cohort Study, 1999–2013
por: Zeitlmann, Nadine, et al.
Publicado: (2016)

National Prevalence and Trends of HIV Transmitted Drug Resistance in Mexico
por: Avila-Ríos, Santiago, et al.
Publicado: (2011)

Calculation of Direct Antiretroviral Treatment Costs and Potential Cost Savings by Using Generics in the German HIV ClinSurv Cohort
por: Stoll, Matthias, et al.
Publicado: (2011)

Correction: National Prevalence and Trends of HIV Transmitted Drug Resistance in Mexico
por: Avila-Ríos, Santiago, et al.
Publicado: (2012)

Why are most organelle genomes transmitted maternally?
por: Greiner, Stephan, et al.
Publicado: (2015)

Persistence of HIV-1 Transmitted Drug Resistance Mutations
por: Castro, Hannah, et al.
Publicado: (2013)

Increase in transmitted resistance to non-nucleoside reverse transcriptase inhibitors among newly diagnosed HIV-1 infections in Europe
por: Frentz, Dineke, et al.
Publicado: (2014)

Antibiotic resistance in prevalent bacterial and protozoan sexually transmitted infections
por: Krupp, Karl, et al.
Publicado: (2015)

Acquired and Transmitted Multidrug Resistant Tuberculosis: The Role of Social Determinants
por: Odone, Anna, et al.
Publicado: (2016)

Insecticide resistance in malaria-transmitting mosquitoes in Zimbabwe: a review
por: Soko, White, et al.
Publicado: (2015)

Resistance of Transmitted Founder HIV-1 to IFITM-Mediated Restriction
por: Foster, Toshana L., et al.
Publicado: (2016)

Mutations that confer resistance to broadly-neutralizing antibodies define HIV-1 variants of transmitting mothers from that of non-transmitting mothers
por: Kumar, Amit, et al.
Publicado: (2021)

Differences in HIV Natural History among African and Non-African Seroconverters in Europe and Seroconverters in Sub-Saharan Africa
por: Pantazis, Nikos, et al.
Publicado: (2012)

Drug Resistance Mutations for Surveillance of Transmitted HIV-1 Drug-Resistance: 2009 Update
por: Bennett, Diane E., et al.
Publicado: (2009)

National molecular surveillance of recently acquired HIV infections in Germany, 2013 to 2014
por: Hauser, Andrea, et al.
Publicado: (2017)

HIV‐1 drug resistance among individuals who seroconverted in the ASPIRE dapivirine ring trial
por: Parikh, Urvi M., et al.
Publicado: (2021)

Characterization of natural polymorphic sites of the HIV-1 integrase before the introduction of HIV-1 integrase inhibitors in Germany
por: Meixenberger, Karolin, et al.
Publicado: (2014)

Scale of knowledge about sexually transmitted infections
por: Nelas, Paula, et al.
Publicado: (2014)

Transmitted Minority Drug-Resistant HIV Variants: A New Epidemic?
por: Deeks, Steven G
Publicado: (2008)

Prevalence of Transmitted HIV Drug Resistance in Iran between 2010 and 2011
por: Jahanbakhsh, Fatemeh, et al.
Publicado: (2013)

Understanding the spread of de novo and transmitted macrolide-resistance in Mycoplasma genitalium
por: Cadosch, Dominique, et al.
Publicado: (2020)

Transmitted drug resistance in patients with acute/recent HIV infection in Brazil
por: Ferreira, Ana Cristina G., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_kaml8egdjp9qatcoj0sbjjdope